Literature DB >> 1270832

Selective action of hydrocortisone on postmitotic epidermal cells in vivo.

E B Laurence, E Christophers.   

Abstract

Hydrocortisone administered systemically for 3 weeks has no effect on any phase of epidermal cell proliferation as measured by autoradiographic methods. However, the speed of cell differentiation (maturation) is increased, resulting in a thinning of the living epidermis due to the shorter epidermal cell life. Comparison of the epidermis from two body sites (ear and sole of foot) in mice receiving 2.4 mug per gm body weight per day of hydrocortisone in drinking water for 3 weeks revealed no change in the labeling with [3H]thymidine, the mitotic indices, or the lengths of the cell cycle phases. Quantitation of the epidermal cell compartments showed that thinning of the epidermis with hydrocortisone was due to the loss of an identical number of differentiating epidermal cells per unit surface from both body sites. In both sites there was the same increased rate of maturation of postmitotic cells while the proliferative cell-pool remained unresponsive to the hormone. The alteration of the speed of cell maturation is the principal action of hydrocortisone in epidermis. The results indicate that the epidermal cellular concentration of, and the susceptibility to, the hormone were identical in ear and sole of foot despite the differing speeds of turnover of the two tissues.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1270832     DOI: 10.1111/1523-1747.ep12482145

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  8 in total

1.  Topical 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibition Corrects Cutaneous Features of Systemic Glucocorticoid Excess in Female Mice.

Authors:  Ana Tiganescu; Melanie Hupe; Yoshikazu Uchida; Theadora Mauro; Peter M Elias; Walter M Holleran
Journal:  Endocrinology       Date:  2018-01-01       Impact factor: 4.736

2.  Effects of glucocorticosteroids on primary human skin fibroblasts. I. Inhibition of the proliferation of cultured primary human skin and mouse L929 fibroblasts.

Authors:  M Ponec; C de Haas; B N Bachra; M K Polano
Journal:  Arch Dermatol Res       Date:  1977-08-22       Impact factor: 3.017

3.  Activators of PPARs and LXR decrease the adverse effects of exogenous glucocorticoids on the epidermis.

Authors:  Marianne Demerjian; Eung-Ho Choi; Mao-Qiang Man; Sandra Chang; Peter M Elias; Kenneth R Feingold
Journal:  Exp Dermatol       Date:  2009-02-19       Impact factor: 3.960

4.  Longitudinal in vivo tracking of adverse effects following topical steroid treatment.

Authors:  Andrew J Bower; Zane Arp; Youbo Zhao; Joanne Li; Eric J Chaney; Marina Marjanovic; Angela Hughes-Earle; Stephen A Boppart
Journal:  Exp Dermatol       Date:  2016-02-13       Impact factor: 3.960

5.  Immunocytochemical localization of glucocorticoid receptor in rat skin.

Authors:  T Karstila; L Rechardt; J Honkaniemi; J A Gustafsson; A C Wikströms; A Karppinen; M Pelto-Huikko
Journal:  Histochemistry       Date:  1994-10

6.  Epidermal thinning: evaluation of commercial corticosteroids.

Authors:  R Wrench
Journal:  Arch Dermatol Res       Date:  1980       Impact factor: 3.017

7.  Stimulation of epidermal protein synthesis in vivo by topical triamcinolone acetonide.

Authors:  C S Harmon; J H Park
Journal:  Biochem J       Date:  1987-11-01       Impact factor: 3.857

Review 8.  Non-invasive Approaches for the Diagnosis of Autoimmune/Autoinflammatory Skin Diseases-A Focus on Psoriasis and Lupus erythematosus.

Authors:  Anna Berekméri; Ana Tiganescu; Adewonuola A Alase; Edward Vital; Martin Stacey; Miriam Wittmann
Journal:  Front Immunol       Date:  2019-08-21       Impact factor: 8.786

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.